OMEROmeros Corporation

$821M

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-87.0% YoY

Gross Profit

$1M87.2% margin

Operating Income

-$28M-1743.6% margin

Net Income

-$30M-1892.6% margin

EPS (Diluted)

$-0.62

QoQ Revenue Growth

-88.5%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$89M

Total Liabilities

$118M

Stockholders' Equity

-$29M

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$12M	-87.0%
Gross Profit	$1M	$12M	-88.4%
Operating Income	-$28M	-$13M	-117.6%
Net Income	-$30M	-$15M	-99.2%

OMER Q1 2018 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena